The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...

The individuals behind Purdue Pharma’s involvement in the U.S. opioid crisis reached a $7-billion settlement in January 2025.

The Office of the Attorney General came to a $7.4 billion settlement with the Sackler family and their company, Purdue Pharma ...

The latest settlement is meant to address a drug addiction crisis that has led to over 700,000 opioid overdose deaths in the US over the past two decades.

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...

Colorado is set to receive around $81 million from a $7.4 billion preliminary settlement with Purdue Pharma, the company’s ...

Purdue Pharma and the Sackler family who controlled it have agreed to pay up to $7.4bn (£6bn) to settle claims regarding its ...

Family and company to make payment to group of US states and other parties to settle long-running litigation over OxyContin’s ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

the new deal will not include a provision that protects the Sackler family from civil litigation – a point of contention that the Supreme Court said violated bankruptcy law. However, they will ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/100.BqoHa0WQ.js ...

If approved, the new plan would end the costliest corporate bankruptcy resulting from the U.S. opioid crisis. Purdue, under the leadership of the Sackler families, invented, manufactured and ...